Home > Healthcare & Medical Devices > Clinical Nutrition Market

Clinical Nutrition Market Size By Product (Infant Nutrition {Milk Based, Soy Based, Organic Formulas}, Enteral Nutrition {Standard Composition, Disease Specific Composition}, Parenteral Nutrition {Amino Acids, Fats, Carbohydrates}), By Consumer (Pediatric, Adult), By Application (Cancer, Metabolic Disorders, Neurological Diseases, Gastrointestinal Disorders), By Distribution Channel (Retail Stores, Pharmacies & Drug Stores, Online Channels), Industry Analysis Report, Regional Outlook, Covid-19 Impact Analysis, Application Potential, Competitive Market Share & Forecast, 2022 – 2030

  • Report ID: GMI1324
  • Published Date: Aug 2022
  • Report Format: PDF

Industry overview

Clinical Nutrition Market size was valued at over USD 47,800 million in 2021. Driven by the high burden of chronic metabolic diseases, the industry is expected to depict a CAGR of 9.3% from 2022 to 2030.
 

Clinical Nutrition Market

Get more details on this report - Request Free Sample PDF
 

Clinical nutrition is emerging as a viable option for disease management since diet is a crucial factor in treatment. The burden of non-communicable diseases such as type-2 diabetes, malnutrition, obesity, and cardiovascular diseases has increased in recent years. According to data from the Centers for Disease Control and Prevention (CDC), in 2020, heart disease claimed the lives of up to 697,000 people in the United States. Coronary heart disease was the most common type, causing 382,820 deaths.
 

The intervention of clinical nutrition for the management and treatment of chronic conditions has become more prominent worldwide. Such ailments lead to prolonged hospitalizations and are associated with higher mortality risk. Lifestyle choices and medical conditions, including diabetes, obesity, and unhealthy diets, also put people at a greater risk of heart disease. This growing incidence of cardiovascular and other chronic conditions will create a strong outlook for the clinical nutrition market players over the forecast period.
 

The escalating rate of premature birth is another factor contributing to industry development. As per the CDC, 1 in 10 births in the U.S. was premature in 2020. Prematurity is one of the leading causes of neonatal mortality across the globe. Infants born with low birth weight also have a risk of developmental delays, infections, and even early death. To boost their survival rate and organ functions, ensuring access to proper nutrients is becoming vital. These high nutritional requirements among premature infants will generate lucrative growth opportunities for the clinical nutrition market.
 

Stringent product regulations may hinder the clinical nutrition industry dynamics

Strict regulatory frameworks associated with clinical nutrition products may create roadblocks to steady market expansion. For example, the U.S. Food and Drug Administration regulates clinical nutrition products under the DSHEA (Dietary Supplement Health and Education Act) of 1994 than drugs and conventional foods. Manufacturers and distributors are also prohibited from commercializing misbranded and adulterated solutions, which may assert an adverse impact on the global industry outlook.
 

Organic infant nutrition product development to gain traction

Global Clinical Nutrition Market share By Product

Get more details on this report - Request Free Sample PDF
 

In terms of product, the market is bifurcated into infant nutrition, parenteral nutrition, and enteral nutrition. The infant nutrition segment among these is anticipated to register a revenue of more than USD 57,300 million by 2030. This can be credited to the rapid introduction of organic and advanced clinical nutrition products fortified with adequate nutrients such as vitamins and protein for infants. The product is also widely accepted across healthcare settings as it helps to significantly curb infant morbidity and mortality.
 

Better access to advanced healthcare facilities will favor the adult segment

Clinical Nutrition Market Share By Consumer

Get more details on this report - Request Free Sample PDF
 

With regards to the consumer, the clinical nutrition market is segmented into pediatric and adult. The adult segment was valued at over USD 19,600 million in 2021 and will amass considerable profits by 2030, owing to the rising number of elderly people with chronic diseases. As per the 2018 National Diabetes Report, nearly 34.2 million people were diagnosed with diabetes in the U.S. Awareness regarding the availability of disease treatment options is increasing among the geriatric population. This factor, alongside favorable medical insurance coverage and increased access to advanced healthcare facilities, will stimulate the development of clinical nutrition centers for adults.
 

Increasing digestive disease diagnosis to push industry growth from gastrointestinal disorders application segment

Based on the application spectrum, the clinical nutrition market is segregated into cancer, metabolic disorders, gastrointestinal disorders, neurological diseases, and others. Among these, the gastrointestinal disorders segment is set to register a revenue of over USD 27,600 million by 2030, given the high incidence of gastroenteritis, Crohn’s disease, and irritable bowel syndrome. According to the 2018 National Ambulatory Medical Care Survey, more than 37 million patients had conducted diagnostic procedures for digestive disorders in the U.S. This factor will drive the consumption of clinical nutrition supplements for effective management of gastrointestinal diseases.
 

Adoption of online marketing strategies will strengthen the clinical nutrition market demand

In terms of the distribution channel, the industry is bifurcated into online channels, pharmacies and drug stores, retail stores, and others. The clinical nutrition industry size from the online channels segment is likely to reach over USD 18,100 million by 2030. Convenience and affordability are some of the prominent factors contributing to the popularity of online sales channels. Several vendors are introducing online platforms to address customer needs. These platforms also provide immediate assistance, quality website interfaces, and detailed product information, which is increasing their demand among consumers.
 

Rising prevalence of Alzheimer's to propel North America clinical nutrition industry expansion

Global Clinical Nutrition Market By Region

Get more details on this report - Request Free Sample PDF
 

Regionally, the North American clinical nutrition market is anticipated to be valued at over USD 26,700 million by 2030. This is due to the high chronic disease prevalence among the elderly population and awareness of artificial nutrition support. Based on the 2021 data from the Alzheimer's Association, nearly 6.2 million people aged 65 years and above were living with Alzheimer's dementia across the U.S. To meet the dietary needs of these patients, evidence-based clinical nutrition therapy has emerged as a significant medical approach.
 

Tech-powered product initiatives to augment the clinical nutrition industry size

Some of the clinical nutrition market players include B Braun Melsungen AG, Abbott Laboratories (Abbott Nutrition), Baxter International Inc., Nestle Health Science, Perrigo, Pfizer, Inc., Danone, AYMES International Ltd, Royal DSM, BASF SE, Hormel Foods Corporation, and others. These companies are mainly emphasizing merger and acquisition strategies to expand their product portfolio and footprint in the market. For instance, in September 2019, B. Braun Melsungen entered a collaboration deal with Smartfish to drive the sales of Remune, its medical nutrition product. The collaboration generated new opportunities for launching innovative products based on Smartfish’s technology.
 

Impact of COVID-19 on the Clinical Nutrition Market Trends

The introduction of lockdowns and other restrictions in wake of the COVID-19 pandemic has asserted an adverse impact on the global healthcare industry. However, the consumption of nutritional products is increasing considerably, especially in home care settings. The rising patient population is also opting for at-home medical nutrition therapies to meet the nutritional requirements without a hospital visit, indicating a positive growth trajectory for the clinical nutrition industry.
 

The Clinical Nutrition market report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2018 to 2030 for the following segments:

By Product

  • Infant Nutrition
    • Milk Based
    • Soy Based
    • Organic Formulas
    • Others
  • Enteral Nutrition
    • Standard Composition
    • Disease Specific Composition
  • Parenteral Nutrition
    • Amino Acids
    • Fats
    • Carbohydrates
    • Others

By Consumer

  • Pediatric
  • Adult

By Application

  • Cancer
  • Metabolic Disorders
  • Neurological Diseases
  • Gastrointestinal Disorders
  • Others

By Distribution Channel

  • Retail Stores
  • Pharmacies & Drug Stores
  • Online Channels
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

 

Authors: Sumant Ugalmugle, Rupali Swain

Frequently Asked Questions (FAQ) :

The global market for clinical nutrition exceeded USD 47,800 million in 2021 and is expected to exhibit a CAGR of 9.3% through 2030, driven by the rising burden of chronic metabolic diseases.

The clinical nutrition industry from the infant nutrition segment is anticipated to register a revenue of over USD 57,300 million in 2030, which can be credited to the rapid introduction of advanced clinical nutrition products for infants.

North America’s clinical nutrition industry is anticipated to be valued at over USD 26,700 million by 2030, due to the high chronic disease prevalence among the elderly population.

Prominent companies partaking in the global clinical nutrition market share include B Braun Melsungen AG, Abbott Laboratories (Abbott Nutrition), Baxter International Inc., Nestle Health Science, Perrigo, Pfizer, Inc., Danone, AYMES International Ltd, Royal DSM, BASF SE, Hormel Foods Corporation, and others.

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies
Immediate Delivery Available

Premium Report Details

  • Base Year: 2021
  • Companies covered: 19
  • Tables & Figures: 411
  • Countries covered: 18
  • Pages: 304

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount